July 4, 2011

A prospective, randomized trial of single-drug versus dual-drug immunosuppression in heart transplantation: the tacrolimus in combination, tacrolimus alone compared (TICTAC) trial


Warning: Invalid argument supplied for foreach() in /nfs/c04/h03/mnt/65750/domains/transplantnow.com/html/wp-content/themes/nephrology/scripts/pubmed.php on line 177

Warning: Invalid argument supplied for foreach() in /nfs/c04/h03/mnt/65750/domains/transplantnow.com/html/wp-content/themes/nephrology/scripts/pubmed.php on line 177

Warning: Invalid argument supplied for foreach() in /nfs/c04/h03/mnt/65750/domains/transplantnow.com/html/wp-content/themes/nephrology/scripts/pubmed.php on line 177
.   .   

The TICTAC trial is the first prospective test of single-drug versus dual-drug maintenance immunosuppression in heart transplantation. Rapid steroid tapering was successful in all study patients. Three-year survival and low rates of allograft rejection and vasculopathy were observed in both arms (either TAC monotherapy or TAC/MMF), supporting the efficacy of either regimen along with a brief course of corticosteroids after transplantation.  Although the study was underpowered, the concept of immunosuppression monotherapy appears to be a safe and feasible option in carefully selected heart transplant recipients.

 

Cardiac Transplantation

Tags: , , , , , ,